PE20000330A1 - NEW CONTRACEPTIVE KIT - Google Patents

NEW CONTRACEPTIVE KIT

Info

Publication number
PE20000330A1
PE20000330A1 PE1999000186A PE00018699A PE20000330A1 PE 20000330 A1 PE20000330 A1 PE 20000330A1 PE 1999000186 A PE1999000186 A PE 1999000186A PE 00018699 A PE00018699 A PE 00018699A PE 20000330 A1 PE20000330 A1 PE 20000330A1
Authority
PE
Peru
Prior art keywords
refers
contraceptive kit
new contraceptive
contraceptive
compound
Prior art date
Application number
PE1999000186A
Other languages
Spanish (es)
Inventor
Helenius Jan Kloosterboer
Godefridus Hermanus Johanna Deckers
Pieter Michiel Verbost
Bennink Herman Jan Tijmen Coelingh
Hamersma Johannes Antonius Maria Maria
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of PE20000330A1 publication Critical patent/PE20000330A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

SE REFIERE A UN ESTEROIDE DE FORMULA I, QUE POSEE ACTIVIDAD PROGESTAGENICA Y ESTROGENICA A UN NIVEL RELATIVAMENTE ALTO POR LO QUE PUEDE SER UTIL COMO ANTICONCEPTIVO, UTILIZANDOSE DE 100ug A 300 ug DEL COMPUESTO I POR 21 A 25 DIAS CONSECUTIVOS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. TAMBIEN SE REFIERE AL USO COMO ANTICONCEPTIVO DE UN COMPUESTO DE FORMULA II, DONDE Y ES (H,H), (O), (N,OH), (H, OH), X ES (-H), (ACILO C2-C7)IT REFERS TO A STEROID OF FORMULA I, WHICH POSSESSES PROGESTAGENIC AND ESTROGENIC ACTIVITY AT A RELATIVELY HIGH LEVEL SO IT MAY BE USEFUL AS A CONTRACEPTIVE, USING FROM 100ug TO 300 ug OF COMPOUND I FOR 21 TO 25 CONSECUTIVE DAYS. IT ALSO REFERS TO A PROCEDURE FOR PREPARATION. IT ALSO REFERS TO THE USE AS CONTRACEPTIVE OF A COMPOUND OF FORMULA II, WHERE Y IS (H, H), (O), (N, OH), (H, OH), X IS (-H), (ACILO C2- C7)

PE1999000186A 1998-03-09 1999-03-09 NEW CONTRACEPTIVE KIT PE20000330A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98200744 1998-03-09

Publications (1)

Publication Number Publication Date
PE20000330A1 true PE20000330A1 (en) 2000-05-16

Family

ID=8233452

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1999000186A PE20000330A1 (en) 1998-03-09 1999-03-09 NEW CONTRACEPTIVE KIT

Country Status (20)

Country Link
EP (1) EP1061928A2 (en)
JP (1) JP2002506014A (en)
KR (1) KR20010041698A (en)
CN (1) CN1292702A (en)
AR (1) AR018313A1 (en)
AU (1) AU756882B2 (en)
BR (1) BR9908605A (en)
CA (1) CA2319765A1 (en)
CO (1) CO5070598A1 (en)
HU (1) HUP0101007A3 (en)
ID (1) ID25621A (en)
IL (1) IL137541A0 (en)
NO (1) NO20004492L (en)
NZ (1) NZ506115A (en)
PE (1) PE20000330A1 (en)
PL (1) PL343428A1 (en)
RU (1) RU2225714C2 (en)
TR (1) TR200002593T2 (en)
WO (1) WO1999045886A2 (en)
ZA (1) ZA991851B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999051214A2 (en) * 1998-04-07 1999-10-14 Akzo Nobel N.V. Progestogen-only contraceptive kit
MXPA02001831A (en) 1999-09-06 2002-10-23 Akzo Nobel Nv Nonaromatic estrogenic steroids with a hydrocarbon substituent in position 11.
AU8201601A (en) 2000-07-28 2002-02-13 Akzo Nobel Nv 16alpha-methyl or ethyl substituted estrogens
EP1482949A1 (en) * 2002-03-11 2004-12-08 Janssen Pharmaceutica N.V. Sulfatase inhibiting progestogen-only contraceptive regimens
AU2003213842A1 (en) * 2002-03-11 2003-09-29 Janssen Pharmaceutica N.V. Sulfatase inhibiting continuous progestogen contraceptive regimens
UA89964C2 (en) 2004-09-08 2010-03-25 Н.В. Органон 15beta-substituted steroids having selective estrogenic activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7701384A (en) * 1977-02-10 1978-08-14 Akzo Nv PROCESS FOR PREPARING NEW STEROIDS FROM THE OESTRAINE SERIES.
DE4227989A1 (en) * 1992-08-21 1994-06-09 Schering Ag Agent for transdermal application containing 3-keto-desogestrel
ZA94715B (en) * 1993-02-08 1994-10-24 Akzo Nv Steroids for treating menopausal complaints

Also Published As

Publication number Publication date
NO20004492D0 (en) 2000-09-08
NO20004492L (en) 2000-09-08
WO1999045886A3 (en) 1999-12-02
ID25621A (en) 2000-10-19
AU756882B2 (en) 2003-01-23
RU2225714C2 (en) 2004-03-20
NZ506115A (en) 2003-07-25
JP2002506014A (en) 2002-02-26
AU3143799A (en) 1999-09-27
CO5070598A1 (en) 2001-08-28
PL343428A1 (en) 2001-08-13
TR200002593T2 (en) 2000-12-21
CN1292702A (en) 2001-04-25
BR9908605A (en) 2001-04-24
ZA991851B (en) 1999-09-22
HUP0101007A2 (en) 2001-12-28
WO1999045886A2 (en) 1999-09-16
IL137541A0 (en) 2001-07-24
AR018313A1 (en) 2001-11-14
CA2319765A1 (en) 1999-09-16
EP1061928A2 (en) 2000-12-27
KR20010041698A (en) 2001-05-25
HUP0101007A3 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
DK1446128T3 (en) Use of estrogen compounds in combination with progestogen compounds in hormone replacement therapy
DK279790A (en) AROMATIC STEROID-5-ALFA REDUCTASE INHIBITORS
BRPI0007487B8 (en) diphenyl-ureas substituted with w-carboxy-aryls as raf kinase inhibitors
BR0113053A (en) Use of benzylidenoaminoguanidines and hydroxyguuanidines as binders to melanocortin receptors
DK1124842T3 (en) Betulinic acid derivatives useful for the treatment of neuroectodermal tumors
WO2002094275A8 (en) Use of estrogen compounds to increase libido in women
TR200102800T2 (en) New compounds.
ES2137549T3 (en) ANTIFUNGAL DERIVATIVES OF SORDARIDINE.
BR9914163A (en) Agent to improve the excretory potency of the urinary bladder, use of a non-carbamate amine compound that has an inhibiting action of acetylcholinesterase, and method to improve the excretory potency of the urinary bladder
AU4246501A (en) 4-fluoroalkyl-2h-benzopyrans with anti-estrogenic activity
ES2063852T3 (en) SUPPRESSION OF THE SYNTHESIS AND SECRETION OF THE PARATHYROID HORMONE WITH VITAMIN DERIVATIVES D3.
PE20000330A1 (en) NEW CONTRACEPTIVE KIT
GB2380939B (en) Treatment or prevention of auto-immune diseases
BR0008437A (en) Steroid sulfatase inhibitors and methods for their manufacture and use
MY128392A (en) 6ALPHA, 9ALPHA-DIFLUORO-17ALPHA-(2-FURANYLCARBOXYL)OXY]-11ß-HYDROXY-16ALPHA-METHYL-3-OXO-ANDROST-1,4,-DIENE-17-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER AS AN ANTI-INFLAMMATORY AGENT
BR9709393A (en) Derivatives of n-bis or n-tris - [(1,2-dicarboxyethoxy) ethyl] amine and preparation and use thereof
ES494653A0 (en) PROCEDURE FOR THE PREPARATION OF NEW AMINO-14 STEROID DERIVATIVES.
BR0009194A (en) Composition of resorcinol
UY26144A1 (en) NEW CRYSTALLINE FORMS OF AN ANTIBIOTIC MACROLID.
BR0013769A (en) Non-aromatic Estrogen Steroids, Pharmaceutical Composition, and Use of a Steroid Compound
BR0211425A (en) Method for the preparation of compounds and use of a composition
BR9812404A (en) Combination of an endothelin antagonist, pharmaceutical preparation, process for preparing a pharmaceutical preparation, and use of a combination of a beta receptor blocker and an endothelin antagonist
NO20031444D0 (en) 17 <alpha> fluoroalkyl steroids, methods of preparation thereof, and pharmaceutical preparations containing the indicated compounds
MX9301939A (en) PHARMACEUTICAL COMPOSITION INCLUDING A STEROIDAL 5-OR-REDUCTASE INHIBITOR COMPOUND.
ES2179206T3 (en) DERIVATIVES OF 12H-DIBENZO (D, G) (1,3) DIOXOCINE.

Legal Events

Date Code Title Description
FC Refusal